ResMed Inc.‘s (RMD) share price has entered into oversold territory with a stochastic value of 17.817. The Zacks Consensus Estimate on the company’s earnings for June 2012 increased by 9 cents over the past month to $1.63 per share. ResMed Inc is a Zacks #2 Rank (“Buy”) company.
To read this article on Zacks.com click here.
Zacks Investment Research
